Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is believed to be an underlying cause of Alzheimer’s disease.
http://dlvr.it/TNx2TY
Posted in
Search Canada Online Listing
Drug to slow early-stage Alzheimer’s disease approved by Health Canada
You May Also Like
More From Author
World Series games really can boost heart rates for fans, cardiologists say
